Tags

Type your tag names separated by a space and hit enter

Acute generalized exanthematous pustulosis (AGEP): A review and update.
J Am Acad Dermatol. 2015 Nov; 73(5):843-8.JA

Abstract

Acute generalized exanthematous pustulosis is a severe cutaneous adverse reaction characterized by the rapid development of nonfollicular, sterile pustules on an erythematous base. It is attributed to drugs in the majority of cases. Antibiotics are the most common cause of acute generalized exanthematous pustulosis; however, a wide variety of drugs has been associated with this condition. Typically, within 48 hours of ingesting the causative medication, there is acute onset of fever and pustulosis with leukocytosis. In severe cases there can be mucous membrane and systemic organ involvement. Histologic findings include intracorneal, subcorneal, and/or intraepidermal pustules with papillary dermal edema containing neutrophils and eosinophils. Treatment focuses on removal of the causative drug, supportive care, infection prevention, and the often beneficial use of a potent topical steroid.

Authors+Show Affiliations

Dermatology, Rutgers New Jersey Medical School, Newark, New Jersey.Dermatology, Rutgers New Jersey Medical School, Newark, New Jersey; Pathology, Rutgers New Jersey Medical School, Newark, New Jersey; Medicine, Rutgers New Jersey Medical School, Newark, New Jersey; Pediatrics, Rutgers New Jersey Medical School, Newark, New Jersey; Preventive Medicine and Community Health, Rutgers New Jersey Medical School, Newark, New Jersey; Rutgers University School of Public Affairs and Administration, Newark, New Jersey. Electronic address: roschwar@cal.berkeley.edu.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

26354880

Citation

Szatkowski, Jesse, and Robert A. Schwartz. "Acute Generalized Exanthematous Pustulosis (AGEP): a Review and Update." Journal of the American Academy of Dermatology, vol. 73, no. 5, 2015, pp. 843-8.
Szatkowski J, Schwartz RA. Acute generalized exanthematous pustulosis (AGEP): A review and update. J Am Acad Dermatol. 2015;73(5):843-8.
Szatkowski, J., & Schwartz, R. A. (2015). Acute generalized exanthematous pustulosis (AGEP): A review and update. Journal of the American Academy of Dermatology, 73(5), 843-8. https://doi.org/10.1016/j.jaad.2015.07.017
Szatkowski J, Schwartz RA. Acute Generalized Exanthematous Pustulosis (AGEP): a Review and Update. J Am Acad Dermatol. 2015;73(5):843-8. PubMed PMID: 26354880.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Acute generalized exanthematous pustulosis (AGEP): A review and update. AU - Szatkowski,Jesse, AU - Schwartz,Robert A, Y1 - 2015/09/06/ PY - 2014/09/08/received PY - 2015/07/10/revised PY - 2015/07/16/accepted PY - 2015/9/11/entrez PY - 2015/9/12/pubmed PY - 2016/1/23/medline KW - T cells KW - acute generalized exanthematous pustulosis KW - drug allergy KW - pustular drug eruption KW - pustules KW - severe cutaneous adverse reactions SP - 843 EP - 8 JF - Journal of the American Academy of Dermatology JO - J Am Acad Dermatol VL - 73 IS - 5 N2 - Acute generalized exanthematous pustulosis is a severe cutaneous adverse reaction characterized by the rapid development of nonfollicular, sterile pustules on an erythematous base. It is attributed to drugs in the majority of cases. Antibiotics are the most common cause of acute generalized exanthematous pustulosis; however, a wide variety of drugs has been associated with this condition. Typically, within 48 hours of ingesting the causative medication, there is acute onset of fever and pustulosis with leukocytosis. In severe cases there can be mucous membrane and systemic organ involvement. Histologic findings include intracorneal, subcorneal, and/or intraepidermal pustules with papillary dermal edema containing neutrophils and eosinophils. Treatment focuses on removal of the causative drug, supportive care, infection prevention, and the often beneficial use of a potent topical steroid. SN - 1097-6787 UR - https://www.unboundmedicine.com/medline/citation/26354880/Acute_generalized_exanthematous_pustulosis__AGEP_:_A_review_and_update_ DB - PRIME DP - Unbound Medicine ER -